CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND CHANGES IN STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Preferred Stock	Treasury Stock	Additional Paid in Capital	Accumulated Deficit
Balance at beginning (in shares) at Dec. 31, 2023		75,879,025
Balance at beginning at Dec. 31, 2023	$ 57,025	$ 8	$ 0	$ (1,019)	$ 204,186	$ (146,150)
Balance at beginning (in shares) at Dec. 31, 2023			165,045
Changes in Stockholders' Equity
Net loss	(19,889)					(19,889)
Issuance of common stock upon vesting of restricted stock (in shares)		83,020
Issuance of common stock upon exercise of options (in shares)		84,649
Issuance of common stock upon exercise of options	73				73
Share-based compensation expense	4,087				4,087
Balance at ending (in shares) at Mar. 31, 2024		76,046,694
Balance at ending at Mar. 31, 2024	$ 41,296	$ 8	$ 0	(1,019)	208,346	(166,039)
Balance at ending (in shares) at Mar. 31, 2024			165,045
Balance at beginning (in shares) at Dec. 31, 2024	75,737,112	77,470,886
Balance at beginning at Dec. 31, 2024	$ 3,589	$ 8	$ 0	(1,019)	215,413	(210,813)
Balance at beginning (in shares) at Dec. 31, 2024	165,045		165,045
Changes in Stockholders' Equity
Net loss	$ (19,585)					(19,585)
Issuance of common stock upon vesting of restricted stock (in shares)		1,023,867
Issuance of common stock upon exercise of options (in shares)		160,537
Issuance of common stock upon exercise of options	$ 137				137
Issuance of common stock upon private placement, net (in shares)	12,006,510
Issuance of common stock upon private placement, net	$ 15,359	$ 1			15,358
Issuance of preferred stock upon exchange of debt for equity (in shares)			37,233
Issuance of preferred stock upon exchange of debt for equity	4,111				4,111
Share-based compensation expense	$ 1,458				1,458
Balance at ending (in shares) at Mar. 31, 2025	88,928,026	90,661,800
Balance at ending at Mar. 31, 2025	$ 5,069	$ 9	$ 0	$ (1,019)	$ 236,477	$ (230,398)
Balance at ending (in shares) at Mar. 31, 2025	202,278		202,278